Watchlist Price Alert

Pyxis Oncology Inc. (PYXS)

NASDAQ: PYXS · Real-Time Price · USD

1.19

-0.02 (-1.65%)

At close: Jun 17, 2025, 3:59 PM

1.19

0.00%

After-hours: Jun 17, 2025, 04:04 PM EDT

Pyxis Oncology Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-77.33M	-73.79M	-120.72M	-75.97M	-12.83M	-2.77M
Depreciation & Amortization	2.98M	1.93M	709K	647K	469K	n/a
Stock-Based Compensation	12.95M	16.95M	15.76M	6.44M	44K	28K
Other Working Capital	-13.02M	-8.16M	12.83M	2.03M	1.73M	213K
Other Non-Cash Items	15.55M	-4.13M	10.41M	20.6M	-56K	-264K
Deferred Income Tax	n/a	n/a	n/a	6.28M	n/a	n/a
Change in Working Capital	-11.82M	-11.66M	4.5M	6.68M	2.29M	505K
Operating Cash Flow	-57.67M	-70.71M	-89.33M	-35.33M	-10.08M	-2.24M
Capital Expenditures	-237K	-6.73M	-6.4M	-540K	-1.48M	n/a
Cash Acquisitions	n/a	6.66M	n/a	-50K	n/a	n/a
Purchase of Investments	-160.12M	-196.83M	n/a	-50K	n/a	n/a
Sales Maturities Of Investments	168.51M	92.05M	n/a	50.05K	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	-50	n/a	n/a
Investing Cash Flow	8.15M	-104.85M	-6.4M	-590K	-1.48M	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-240K	-193K	183K	167K	32K	21.95M
Financial Cash Flow	59.33M	5.93M	183K	304.04M	35K	21.95M
Net Cash Flow	9.81M	-169.63M	-95.55M	268.13M	-11.53M	19.72M
Free Cash Flow	-57.91M	-77.44M	-95.73M	-35.87M	-11.57M	-2.24M